NBRV - Nabriva Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts6678
Avg. Estimate-0.59-0.58-2.21-2.03
Low Estimate-0.75-0.74-2.85-3.2
High Estimate-0.49-0.42-1.65-1.05
Year Ago EPS-0.56-0.54-2.49-2.21
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts5578
Avg. Estimate1.16M1.24M4.77M15.23M
Low Estimate1M1M3M8.81M
High Estimate1.7M1.8M7.4M22.9M
Year Ago Sales1.68M1.05M5.32M4.77M
Sales Growth (year/est)-30.90%18.00%-10.30%219.30%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-5.48-0.6-0.58-0.57
EPS Actual-0.56-0.54-0.79-0.61
Difference4.920.06-0.21-0.04
Surprise %89.80%10.00%-36.20%-7.00%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.59-0.58-2.21-2.03
7 Days Ago-0.59-0.58-2.21-2.03
30 Days Ago-0.56-0.57-2.31-2.29
60 Days Ago-0.58-0.56-2.29-2.31
90 Days Ago-0.58-0.56-2.31-2.35
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1133
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNBRVIndustrySectorS&P 500
Current Qtr.-5.40%N/AN/A0.42
Next Qtr.-7.40%N/AN/A0.38
Current Year11.20%N/AN/A0.20
Next Year8.10%N/AN/A0.10
Next 5 Years (per annum)25.75%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A